Skip to main content
Clinical Trials/CTRI/2024/08/071971
CTRI/2024/08/071971
Not yet recruiting
未知

Comparison of efficacy, safety and cost effectiveness of montelukast plus bilastine versus montelukast plus levocetirizine in patients of allergic rhinitis: prospective , randomised, open label parallel study - Nil

Dr Ganesh Dakhale0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Sponsor
Dr Ganesh Dakhale
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Ganesh Dakhale

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients suffering from non\-specific allergic rhinitis of either gender, in age group 18 to 65 years.
  • 2\. History of intermittent or persistent allergic rhinitis of any severity with no obvious cause prior to inclusion in study.
  • 3\. Patients with TNSS greater than 8 not treated with anti\-histamines in last 7 days.

Exclusion Criteria

  • 1\. History of asthma requiring chronic use of inhaled corticosteroids.
  • 2\. Had been unresponsive to anti\-histamine in the past.
  • 3\. History of allergy to the study medication or unable to tolerate anti\-histamines.
  • 4\. Use of study drug in last 1 week prior to baseline.
  • 5\. Pregnant and nursing women.
  • 6\. Subjects with history of significant haematopoietic, hepatic, renal, cardiovascular, neurological, psychiatric or autoimmune disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials